Europe PMCopen access
Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry
Antibodies, Native Mass Spectrometry, Biopharma, Intact Analysis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 642664
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.